Visit the Beamex web site
Click on the advert above to visit the company web site

Product category: Pharmaceutical Processing News
News Release from: GEA Process Engineering
Edited by the Processingtalk Editorial Team on 02 November 2006

New Sales and Marketing Director for NPS

Request your FREE weekly copy of the Processingtalk email newsletter. News about Pharmaceutical Processing News and more every issue. Click here for details.

Frans K.A Maas has been appointed as Group Director Sales and Marketing for Niro Pharma Systems (NPS), a part of the GEA Group, based in Collette in Belgium

Frans K.A Maas has been appointed as Group Director Sales and Marketing for Niro Pharma Systems (NPS) part of GEA Group (GEA) NPS consists of the technologies of well established pharmaceutical brand names: Aeromatic, Buck, Collette, Courtoy, Fielder, Lyophil, Nica and Niro

His job will be to drive the sales and marketing operations for NPS in all locations worldwide working closely with the business units in Europe and the NPS operations in Asia and the US.

Frans will be the successor to Milo de Naeghel who, after 40 years working in the capital goods industry, will retire at the end of this year.

Frans is 43 years old and lives in the Netherlands.

He will be based at Collette (Belgium).

Previously he spent 4 years as a business consultant, 10 years with General Electric and 4 years with BOC Edwards Pharmaceutical Systems in various manufacturing, sales and general management roles.

He is looking forward to using his considerable experience of international business and building multi-cultural teams to bring tangible benefits to NPS and its customers.

Talking about his new role Frans said that was able to offer an objective view of the applications and opportunities available for new technologies in the pharmaceutical industry.

"In the coming years the pharmaceutical industry will see many changes caused by continued industrial globalisation, the drive to generics, the growth of the biological sector and the explosion of the Asian markets," he said.

"Our prime growth will come from the supply of integrated systems and our success will be determined by our ability to limit project risk and provide excellent value for our customers throughout the whole product life cycle.

We want to lead this transition by using the technologies within NPS to meet our customers needs and give them a competitive advantage.

I am delighted to be part of such a dynamic organisation at this exciting time".

Ron Youngs, Group Managing Director of NPS said, "We are thrilled to have Frans on board.

I am convinced that his international experience will help us in developing a deeper understanding of how best we can meet our customers needs in the future.

I see this as critical in ensuring the continuing growth of the Niro Pharma Systems business in what is a truly global market." NPS is part of the GEA Process Engineering Division.

Its members provide a wide range of services to the pharmaceutical market focused on the solid dosage and sterile products sectors.

Products include: granulation and drying equipment, tablet presses, high-containment valve technology, bulk handling systems, coating and pelletisation products, spray dryers, liquid parenteral lines, freeze drying systems and specialist laboratory equipment.

GEA Process Engineering: contact details and other news
Email this article to a colleague
Register for the free Processingtalk email newsletter
Processingtalk Home Page

Search the Pro-Talk network of sites

Visit the Beamex web site